Ocugen, Inc. Signs Letter of Intent to Acquire Vaccine
Dormant Vaccine Manufacturing site currently owned by an affiliate of Liminal BioSciences intended to bring new capabilities to Ocugen’s medicine portfolio...
Stay updated with breaking news from Vaccigen Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dormant Vaccine Manufacturing site currently owned by an affiliate of Liminal BioSciences intended to bring new capabilities to Ocugen’s medicine portfolio...
Bharat Biotech partner Ocugen seeks approval for Covaxin in Canada Ocugen Inc., Bharat Biotech's partner for USA and Canada for COVID-19 vaccine Covaxin has initiated a rolling submission to Health Canada for the jab, the US company said in a regulatory filing. The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, it said on Thursday. Often referred to as a rolling review, this allows Health Canada to start its review right away, as information continues to come in, to accelerate the overall review...